Loading clinical trials...
Loading clinical trials...
Study to Assess the Safety and Effect of Repeated Administration of Granulocyte Colony-Stimulating Factor (G-CSF; Filgrastim) on Hot Flashes and Other Vasomotor Symptoms of Menopause in Postmenopausal Women
Conditions
Interventions
G-CSF
Placebo/Saline
Locations
2
United States
Site 2
Aurora, Colorado, United States
Site 1
Denver, Colorado, United States
Start Date
August 6, 2018
Primary Completion Date
January 21, 2022
Completion Date
February 22, 2022
Last Updated
November 28, 2023
NCT04893226
NCT05351476
NCT04312399
NCT04045379
NCT06794346
NCT07424521
Lead Sponsor
MenoGeniX, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions